Why Rhythm Pharmaceuticals Stock Triumphed on Tuesday
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
Learn about the best cash back rewards cards that come with no fees. Maximize your benefits today!
23,366 articlesA standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
Cerebras Systems jumped after its IPO, but is it too late to join the rally? This guide breaks down the tech, market ...
Peloton stock popped today as traders weighed potential index moves and improving momentum. This guide breaks down th...
Eagle Point Credit Company touts an 18% yield, yet its portfolio centers on CLO equity tranches—the most volatile seg...
Three mid-cap SaaS stocks are under renewed activist scrutiny as AI-fit strategies collide with balance-sheet pressur...
Synopsys, a leader in chip design software, trades below its 52-week high even as revenue grows, highlighting investo...
Casey’s General Stores prepares to report Q4 results after the bell, with analysts weighing margins in prepared foods...
SpaceX may be the headline grabber, but buying on day one isn’t a slam-dunk. This guide gives you three essential que...
In Q1 2026, Alphabet leverages cloud and AI families to expand, while Meta doubles down on ads. The split underscores...
A seismic shift in how the Fed communicates could redefine market expectations. This piece examines kevin warsh shift...
Bitcoin and gold are drifting lower as investors rotate into traditional equities and bonds. Analysts are asking wher...